Antioxidant effects of some drugs on immobilization stress combined with cold restraint stress

Molecules

Volumn 14, Issue 11, 2009, Pages 4505-4516

  Popovic, Mira ^a   Janicijevic Hudomal, Snezana ^b   Kaurinovic, Biljana ^a   Rasic, Julijana ^b   Trivic, Svetlana ^a   Vojnović, Matilda ^c  

^a UNIVERSITY OF NOVI SAD   (Serbia)

^b UNIVERSITY OF PRI TINA   (Serbia)

^c Health Center   (Serbia)

Author keywords

Antioxidative status; Azithromycin; Bromocriptine; Cold restraint stress; Haloperidol; Immobilization stress; Morphine; Tramadol

Indexed keywords

ANTIOXIDANT; AZITHROMYCIN; BROMOCRIPTINE; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HALOPERIDOL; HYDROGEN PEROXIDE; MORPHINE; REACTIVE OXYGEN METABOLITE; TRAMADOL;

ANIMAL; ARTICLE; COLD; DRUG EFFECT; IMMOBILIZATION; LIPID PEROXIDATION; MALE; METABOLISM; OXIDATIVE STRESS; PHYSIOLOGICAL STRESS; PHYSIOLOGY; RAT; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; AZITHROMYCIN; BROMOCRIPTINE; CATALASE; COLD TEMPERATURE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HALOPERIDOL; HYDROGEN PEROXIDE; IMMOBILIZATION; LIPID PEROXIDATION; MALE; MORPHINE; OXIDATIVE STRESS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; STRESS, PHYSIOLOGICAL; TRAMADOL;

EID: 73349133710     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules14114505     Document Type: Article

References (46)

1. Robert, A.; Szabo, S. Stress ulcers. In Seyles Guide to Stress Research; Seyle, H., Ed.; Van Nostrand Reinhold Company Inc: New York, NY, USA, 1983; Volume 2, pp. 22-46
2. Bannwarth, B. Risk-benefit Assessment of Opioids in Chronic Noncancer Pain; Drug Saf. 1999, 21, 283-296.
3. Quang-Cantagrel, N. D.; Wallace, M. S.; Magnuson, S. K. Opioid Substitution to Improve the Effectiveness of Chronic Noncancer Pain Control a Chart Review. Anesth. Analg. 2000, 90, 933-937.
4. Collet, B. J. Chronic Opioid Therapy for Non-Cancer Pain. Br. J. Anaesth. 2001, 87, 133-143.
5. Pacifici, G. M.; Bencini, C.; Rane, A. Presystemic Glucuronidation of Morphine in Humans and Rhesus Monkeys: Subcellular Distribution of the UDP-Glucuronyltransferase in the Liver and Intestine. Xenobiotica 1986, 16, 123-128.
6. Stain-Texier, F.; Sandouk, P.; Scherrann, J. M. Intestinal Absorption and Stability of Morphine 6-Glucuronide in Different Physiological Compartments of the Rat. Drug. Metab. Dispos. 1998, 26, 383-387.
7. Lee, C. R.; McTavish, D.; Sorkin, E. M. Tramadol. A Preliminary Review of its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Potential in Acute and Chronic Pain States. Drugs 1993, 46, 313-340.
8. Petropoulos, A. D.; Kouvela, E. C.; Starosta, A. L.; Wilson, D. N.; Dinos, G. P.; Kalpaxis, D. L. Time-Resolved Binding of Azithromycin to Escherichia coli Ribosomes. J. Mol. Biol. 2009, 38, 1179-1192.
9. Bakar, O.; Demircay, Z.; Yuksel, M.; Haklar, G.; Sanisoglu, Y. The Effect of Azithromycin on Reactive Oxygen Species in Rosacea. Clin. Exper. Derm. 2007, 32, 197-200.
10. Culic, O.; Erakovic, V.; Cepelak, I.; Barisic, K.; Brajsa, K.; Ferencic, Z.; Galovic, R.; Glojnaric, I.; Manojlovic, Z.; Munic, V.; Novak-Mircetic, R.; Pavicic-Beljak, V.; Sucic, M.; Veljaca, V.; Zanic-Grubisic, T.; Parnham, M. J. Azithromycin Modulates Neutrophil Function and Circulating Inflammatory Mediators in Healthy Human Subjects Eur. J. Pharmacol. 2002, 450, 277-289.
11. Tsai, W. C.; Rodriguez, M. L.; Young, K. S.; Deng, J. C.; Thannickal, V. J.; Tateda, K.; Hershenson, M. B.; Standiford, T. J. Azithromycin Blocks Neutrophil Recruitment in Pseudomonas Endobronchial Infection. Am. J. Respir. Crit. Care Med. 2004, 170, 1331-1339.
12. Parnhama, M. J.; čulić, O.; Eraković, V.; Munić, V.; Popović-Grle, S.; Barišić, K.; Bosnar, M.; Brajša, K.; čepelak, I.; čužić, S.; Glojnarić, I.; Manojlović, Z.; Novak-Mirčetić, R.; Oresković, K.; Pavičić-Beljak, V.; Radošević, S.; Sučić, M. Modulation of Neutrophil and Inflammation Markers in Chronic Obstructive Pulmonary Disease by Short-Term Azithromycin Treatment. Eur. J. Pharm. 2005, 517, 132-143.
13. Sitland-Marken, P. A.; Wells, B. G.; Froemming, J. H.; Chu, C. C.; Brown, C. S. Psychiatric Applications of Bromocriptine Therapy. J. Clin. Psychiatry 1990, 51, 68-82.
14. Schapira, A. H. Neuroprotection in PDA Role for Dopamine Agonists? Neurology 2003, 61, 34-42.
15. Yoshikawa, T.; Minamiyama, Y.; Naito, Y.; Kondo, M. Antioxidant Properties of Bromocriptine, a Dopamine Agonist. J. Neurochem. 1994, 62, 1034-1038.
16. Muralkrishnan, D.; Mohanakumar, K. P. Neuroprotection by Bromocriptine against 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyridine-Induced Neurotoxicity in Mice. FASEB J. 1998, 12, 905-912.
17. Lim, J. H.; Kim, K. M.; Kim, S. W.; Hwang, O.; Choi, H. J. Bromocriptine Activates NQO1 via Nrf2-PI3K/Akt Signaling: Novel Cytoprotective Mechanism against Oxidative Damage. Pharmacol. Res. 2008, 57, 325-331.
18. Subramaniam, B.; Rollema, H.; Woolf, T.; Castagnoli, N. G. Identification of a Potentially Neurotoxic Pyridinium Metabolite of Haloperidol in Rats. Biochem. Biophys. Res. Commun. 1990, 166, 238-244.
19. Cadet, J. L.; Lohr, J. B. Possible Involvement of Free Radicals in Neuroleptic-Induced Movement Disorders. Ann. NY Acad. Sci. 1989, 570, 176-185.
20. Thaakur, S. R.; Jyothi, B. Effect of Spirulina Maxima on the Haloperidol Induced Tardive Dyskinesia and Oxidative Stress in Rats. J. Neural. Transm. 2007, 114, 1217-1225.
21. Creese, I.; Burt, D. R.; Synder, S. H. Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs. Science 1976, 192, 481-483.
22. Walker, J. M.; Bowen, W. D.; Walker, F. O.; Matsumoto, R. R.; De Costa, B.; Rice, C. K. Sigma receptors: biology and function. Pharmacol. Rev. 1990, 42, 355-402.
23. Vilner, B. J.; de Costa, BR; Bowen, W. D. Cytotoxic effects of sigma ligands: Sigma receptormediated alterations in cellular morphology and viability. J. Neurosci. 1995, 15, 117-134.
24. Rietjens, I. M. C. M.; Boersma. M. G.; de Haan, L.; Spenkelink, B.; Awad, H. M.; Cnubben, N. H. P.; van Zanden. J. J.; van der Woude, H.; Alink, G. M., Koeman, J. H. The pro-oxidant chemistry of the natural antioxidants vitamin C, vitamin E, carotenoids and flavonoids. Environ. Toxicol. Pharmacol. 2002, 11, 321-333.
25. Yao, J. K.; Reddy, R.; McElhinny, L. G.; van Kammen, D. P. Effects of Haloperidol on Antioxidant Defense System Enzymes in Schizophrenia. J. Phys. Res. 1998, 32, 385-391.
26. Naidu, P. S.; Singh, A.; Kulkarni, S. K. Quercetin, a Bioflavonoid, Attenuates Haloperidol-Induced Orofacial Dyskinesia. Neuropharmacology 2003, 44, 1100-1106.
27. Smirnova, G. V.; Zakirova, O. N.; Oktyabrskii, O. N. The Role of Antioxidant Systems in the Cold Stress Response of Escherichia coli. Microbiology 2001, 70, 45-50.
28. Yüksel, S.; Asmab, D. Effects of Extended Cold Exposure on Antioxidant Defense System of Rat Hypothalamic-Pituitary-Adrenal Axis. J. Thermal Biol. 2006, 31, 313-317.
29. Latyshko, N.; Gudkova, L.; Gudkova, O.; Mykhailovsky, V. Molecular Mechanisms of Catalase Action Under Cold Stress Conditions. Annales Universitatis Mariae Curie-Sklodowska 2006, 19, 159-162.
30. Popovic, M.; Janicijevic-Hudomal, S.; Kaurinovic, B.; Rasic, J.; Trivic. S. Antioxidant Effects of Some Drugs on Ethanol-Induced Ulcers. Molecules 2009, 14, 816-826.
31. Lurie, E.; Soloviova, A.; Alyabieva, T.; Kaplun, A.; Panchenko, L.; Shvets, V. Effect of Novel Aromatic Derivative of GABA on Lipid Peroxidation in Chronically Morphinized Rats. Biochem. Mol. Biol. Int. 1995, 36, 13-19.
32. Masini, A.; Gallesi, D.; Giovannini, F.; Trenti, T.; Ceccarelli, D. Membrane Potential of Hepatic Mitochondria after Acute Cocaine Administration in Rats-The Role of Mitochondrial Reduced Glutathione. Hepatology 1997, 25, 385-390.
33. Panchenko, L. F.; Pirozhkov, S. V.; Nadezhdin, A. V.; Baronets, V. I.; Usmanova, N. N. Lipid Peroxidation, Peroxyl Radicalscavenging System of Plasma and Liver and Heart Pathology in Adolescence Heroin Users. Vopr. Med. Khim. 1999, 45, 501-506.
34. Atici, S.; Cinel, I.; Cinel, L.; Doruk, N.; Eskandari, G.; Oral, U. Liver and Kidney Toxicity in Chronic Use of Opioids: An Experimental Long Term Treatment Model. J. Biosci. 2005, 30, 245-252.
35. Zhang, Y. T.; Zheng, Q. S.; Pan. J.; Zheng, R. L. Oxidative Damage of Biomolecules in Mouse Liver Induced by Morphine and Protected by Antioxidants. Basic Clin. Pharmacol. Toxicol. 2004, 95, 53-58.
36. William, S.; Sekar, N.; Subramanian, S.; Govindasamy, S. Toxic Effect of Morphine and the Antagonistic Role of Naloxone on Isolated Rat Hepatocytes. Biochem. Int. 1991, 23, 1071-1077.
37. Bosma, H,; Peter, R.; Siegrist, J.; Marmot, M. Two alternative job stress models and the risk of coronary heart disease. Am. J. Public Health 1998, 88, 68-74.
38. Azam, F. Synthesis of Some Urea and Thiourea Derivatives of Naphtha[1, 2-d]Thiazol-2-Amine as Anti-Parkinsonian Agents that Cause Neuroprotection against Haloperidol-Induced Oxidative Stress in Mice. Med. Chem. Res. 2009, 18, 287-308.
39. Buege, A. J.; Aust, D. S. Methods in Enzymology; Fleischer, S., Parker, L., Eds.; Academic Press: New York, USA, 1988; p. 306.
40. Simon, L. M.; Fatrai, Z.; Jonas, D. E.; Matkovics, B. Study of Metabolism Enzymes during the Development of Phaseolus vulgaris. Biochem. Physiol. Plant 1974, 166, 389-393.
41. Beers, R. F. J.; Sizer, J. W. Spectrophotometric Method for Measuring of Breakdown of Hydrogen Peroxide by Catalase. J. Biol. Chem. 1950, 195, 133-140.
42. Chin, P. T. Y.; Stults, F. H.; Tappel, A. L. Purification of Rat Lung Soluble Glutathione Peroxidase. Biochem. Biophys. Acta 1976, 445, 558-660.
43. Bergmayer U. H. Methoden Der Enzymatischen Analyse. Verlag Chemie: Weinhem, Germany, 1970.
44. Glatzle, D.; Vuillenmir, K. Glutathione Reductase Test with Whole Blood a Convenient Procedure for the Assessment of the Riboflavin Status in Human. Experimentia 1974, 30, 565-638.
45. Kapetanović, I. M.; Mieyal, I. I. Inhibition of Acetaminophen Induced Hepatotoxicity by Phenacetin and Its Alkoxy Analogs. J. Pharmacol. Exp. Ther. 1979, 209, 25-30.
46. Gornall, H. G.; Nardwall, C. L. Estimation of Total Protein in Tissue Homogenate. J. Biol. Chem. 1949, 177, 751-756. © 2009